Search Results - "VON WUSSOW, P"

Refine Results
  1. 1

    Effective Natural Interferon-α Therapy in Recombinant Interferon-α-Resistant Patients With Hairy Cell Leukemia by Wussow, P. von, Pralle, H., Hochkeppel, H.-K., Jakschies, D., Sonnen, S., Schmidt, H., Miiller-Rosenau, D., Franke, M., Haferlach, T., Zwingers, T., Rapp, U., Deicher, H.

    Published in Blood (01-07-1991)
    “…To explore the relationship between anti-interferon-α (anti-IFN-α) antibodies and loss of clinical responsiveness to IFN-α treatment, we examined sera from 59…”
    Get full text
    Journal Article
  2. 2

    Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS by KRACKE, A, VON WUSSOW, P, AL-MASRI, A. N, DALLEY, G, WINDHAGEN, A, HEIDENREICH, F

    Published in Neurology (11-01-2000)
    “…To correlate Mx protein (Mx) levels in lysed blood leukocytes with the clinical response to interferon (IFN) beta-1b (IFNbeta-1b) in relapsing-remitting MS…”
    Get full text
    Journal Article
  3. 3

    A whole blood immunoassay for the interferon-inducible human Mx protein by Towbin, H, Schmitz, A, Jakschies, D, Von Wussow, P, Horisberger, M A

    Published in Journal of interferon research (01-04-1992)
    “…Mx protein, an intracellular protein induced by type I interferons (IFNs), is useful as a marker for the IFN-induced state. It is detectable, for example, in…”
    Get more information
    Journal Article
  4. 4

    Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schönlein purpura by Floege, Jürgen, Burg, Michael, Al Masri, Abdul N., Gröne, Hermann Joseph, von Wussow, Peter

    Published in American journal of kidney diseases (01-03-1999)
    “…Both viral infections and dysregulated cytokine synthesis have been implicated in the pathogenesis of immunoglobulin A nephropathy (IgAN) and Henoch-Schönlein…”
    Get full text
    Journal Article
  5. 5

    Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo by Davis-Daneshfar, A, Böni, R, von Wussow, P, Joller, H, Burg, G, Dummer, R

    Published in Journal of immunotherapy (1997) (01-05-1997)
    “…In an adjuvant clinical trial for high-risk patients with malignant melanoma by using recombinant interleukin-2 (rIL-2) and recombinant interferon-alpha 2b…”
    Get more information
    Journal Article
  6. 6

    Presence of interferon and anti-interferon in patients with systemic lupus erythematosus by von Wussow, P, Jakschies, D, Hartung, K, Deicher, H

    Published in Rheumatology international (01-01-1988)
    “…Sera from 61 patients with systemic lupus erythematosus (SLE) were serially screened over a period of at least 2 years for IFN and anti-IFN antibodies. IFN…”
    Get full text
    Journal Article
  7. 7

    Common variable immunodeficiency (CVID) and MxA‐protein expression in blood leucocytes by RUMP, J. A., JAKSCHIESS, D., WALKER, U., SCHLESIER, M., WUSSOW, P., PETER, H. H.

    Published in Clinical and experimental immunology (01-07-1995)
    “…SUMMARY The underlying immunopathogenic mechanism of CVID has been suspected to involve a chronic viral infection or an autoimmune condition. However, formal…”
    Get full text
    Journal Article
  8. 8

    Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin by al-Masri, A N, Werfel, T, Jakschies, D, von Wussow, P

    Published in Molecular pathology (01-02-1997)
    “…AIM/BACKGROUND: The Mx proteins are known to be specifically and dose dependently induced in mononuclear cells (MNC) by type I interferons (IFN). The aim of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Role of interferon in natural kill of HSV-1-infected fibroblasts by Fitzgerald, PA, von Wussow, P, Lopez, C

    Published in The Journal of immunology (1950) (01-08-1982)
    “…The production of interferon during natural killer (NK) assays against HSV-1-infected fibroblasts (NK(HSV-1)) was studied to determine whether this interferon…”
    Get full text
    Journal Article
  11. 11

    Low dose alpha interferon treatment in chronic hepatitis B virus infection by MÜLLER, R, BAUMGARTEN, R, MALMUS, K, SCHMIDT, F. W, MARKUS, R, SCHULZ, M, WITTENBERG, H, HINTSCHE-KILGER, B, FENGLER, J.-D, VON WUSSOW, P, MEISEL, H, KLEIN, H

    Published in Gut (1993)
    “…Fifty eight patients with chronic viral hepatitis B (HBV) were randomised in a prospectively controlled trial. Thirty patients were treated with 3 million…”
    Get full text
    Conference Proceeding Journal Article
  12. 12

    Treatment of chronic hepatitis B with interferon alfa-2b by Müller, R, Baumgarten, R, Markus, R, Schulz, M, Wittenberg, H, Hintsche-Kilger, B, Fengler, J D, Von Wussow, P, Meisel, H, Klein, H

    Published in Journal of hepatology (1990)
    “…A total of 58 patients with histologically confirmed chronic viral hepatitis B and presence of hepatitis B surface antigen and hepatitis B virus DNA (HBV DNA)…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells by von Wussow, P, Platsoucas, CD, Wiranowska-Stewart, M, Stewart, WE, 2d

    Published in The Journal of immunology (1950) (01-09-1981)
    “…The murine monoclonal antibody OKT3 (IgG2), which recognizes the majority of human E-rosette-forming cells, was found to induce interferon (IFN) production in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor by Becker, J C, Dummer, R, Von Wussow, P, Burg, G, Schmidt, R E

    Published in Scandinavian journal of immunology (01-08-1992)
    “…Non-specific antibody production usually accompanies the T-cell-regulated B-cell response. In this paper the mechanisms involved in non-MHC-restricted T-B-cell…”
    Get more information
    Journal Article
  18. 18

    Factors inhibiting IFN activity by Schellekens, H, van der Meide, P H, von Wussow, P

    Published in Biotherapy (Dordrecht) (01-01-1996)
    “…Several factors may inhibit the activity of IFNs. Some of these occur naturally, others are therapy-induced or artificial. Naturally occurring antibodies…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Incidence of AIDS- and non-AIDS-defining malignomas in HIV-positive patients—A nation-wide German overview 2000–2002 by Mosthaf, F. A., Goetzenich, A., Ostrop-Hanhoff, N. J., Wolf, E., Knechten, H., Von Wussow, P.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 7554 Background: The primary purpose of this study was to gather data on the epidemiology of AIDS- and non-AIDS-defining malignomas in…”
    Get full text
    Journal Article